Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
Gilead→Tubulis
Apr 7, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Tracking 334 platform M&A deals. Browse platform transactions across all sectors and states.
Gilead→Tubulis
Apr 7, 2026
North American Construction Group→Iron Mine Contracting
Apr 7, 2026
Sportsbox AI
Apr 7, 2026
Dawson Partners
Apr 7, 2026
PROG Holdings→P-Squared
Apr 7, 2026
Western Realco→Anaheim Development Site
Apr 6, 2026
Knightvest Capital→Ardan apartments
Apr 6, 2026
Cencora→EyeSouth Retina Business
Apr 6, 2026
Brink’s→NCR Atleos
Apr 6, 2026
Dalfen Industrial
Apr 6, 2026
Bureau Veritas→Lotusworks
Apr 6, 2026
DOXA→Jupiter Underwriting Group
Apr 6, 2026
Yuzu Health
Apr 6, 2026
Neurocrine→Soleno Therapeutics
Apr 6, 2026
Uplift Investors→IMS Legal Strategies
Apr 6, 2026
Nuvini→Beyondsoft
Apr 6, 2026
Inspira Technologies→AME platform
Apr 6, 2026
ECP→EnergySolutions
Apr 6, 2026
Whiteoak→Zeus Street Greek
Apr 6, 2026
Repay Holdings→KUBRA
Apr 6, 2026